1. Referable Macular Hemorrhage—A Clinically Meaningful Screening Target in Newborn Infants. Position Statement of the Association of Pediatric Retina Surgeons
- Author
-
Edward H. Wood, Antonio Capone, Kimberly A. Drenser, Audinal Berrocal, G. Baker Hubbard, Natalia F. Callaway, Andres Kychenthal, Anna Ells, Clio A. Harper, Cagri Giray Besirli, Caroline R. Baumal, Demetrios G. Vavvas, Emmanuel Y. Chang, Eric D. Nudleman, Irena Tsui, Jonathan Sears, Lejla Vajzovic, Mary E. Hartnett, Michael J. Shapiro, Polly A. Quiram, Sengul Ozdek, Shunjil Kusaka, Wei-Chi Wu, and Michael T. Trese
- Subjects
Surgeons ,Neonatal Screening ,Eye Diseases ,Infant, Newborn ,Humans ,Infant ,Retinal Hemorrhage ,Child ,Retina - Abstract
Universal newborn eye screening facilitates early diagnosis of ocular abnormalities and mitigates vision loss. “Referral warranted” eye disease is present at birth in about 5.5% of term infants, with “macular hemorrhage impinging on the fovea” representing about 50% of referral warranted disease. The Association of Pediatric Retina Surgeons held a symposium on February 9, 2021 that culminated in a position statement on “referable macular hemorrhage” (RMH) in newborn infants. RMH is meaningful in that in can cause amblyopia through deprivation, can be readily captured with wide-angle photography in a safe and efficient manner, and may lead to early intervention with mitigation of vision loss. [ Ophthalmic Surg Lasers Imaging Retina . 2022;53:3–6.]
- Published
- 2022
- Full Text
- View/download PDF